We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+5.52%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$424M
AUM Growth
+$9.9M
Cap. Flow
-$11.1M
Cap. Flow %
-2.62%
Top 10 Hldgs %
44.82%
Holding
68
New
3
Increased
11
Reduced
40
Closed
3

Top Buys

Rank Stock Value
1
KEYS icon
Keysight
KEYS
+$6.15M
2
EFX icon
Equifax
EFX
+$3.92M
3
CHRW icon
C.H. Robinson
CHRW
+$3.51M
4
PM icon
Philip Morris
PM
+$2.69M
5
AXTA icon
Axalta
AXTA
+$2.44M

Top Sells

Rank Stock Value
1
HSY icon
Hershey
HSY
+$5.44M
2
CTVA icon
Corteva
CTVA
+$4.1M
3
MSFT icon
Microsoft
MSFT
+$2.54M
4
CSCO icon
Cisco
CSCO
+$2.27M
5
BTI icon
British American Tobacco
BTI
+$1.85M

Sector Composition

Rank Sector Weight
1 Healthcare 22.62%
2 Technology 22.53%
3 Industrials 19.01%
4 Consumer Staples 11.87%
5 Consumer Discretionary 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIN icon
26
Linde
LIN
$221B
$5.92M 1.4%
21,142
-684
-3% -$177K
ROST icon
27
Ross Stores
ROST
$80.5B
$5.71M 1.35%
47,576
+19,464
+69% +$2.31M
PFE icon
28
Pfizer
PFE
$143B
$5.32M 1.25%
146,753
-45,058
-23% -$1.6M
CTVA icon
29
Corteva
CTVA
$52.6B
$5.05M 1.19%
108,283
-92,733
-46% -$4.1M
KO icon
30
Coca-Cola
KO
$377B
$4.94M 1.16%
93,720
CPRT icon
31
Copart
CPRT
$27B
$4.89M 1.15%
180,080
-10,004
-5% -$282K
NVS icon
32
Novartis
NVS
$297B
$4.82M 1.14%
56,373
-877
-2% -$78.7K
ULTA icon
33
Ulta Beauty
ULTA
$22B
$4.62M 1.09%
14,927
-3,457
-19% -$1.07M
CME icon
34
CME Group
CME
$96.3B
$4.33M 1.02%
21,177
-1,006
-5% -$198K
SBUX icon
35
Starbucks
SBUX
$120B
$4.29M 1.01%
39,240
-3,979
-9% -$418K
ALSN icon
36
Allison Transmission
ALSN
$9.5B
$4.2M 0.99%
102,946
-2,280
-2% -$94.9K
BRK.B icon
37
Berkshire Hathaway Class B
BRK.B
$1.1T
$4.17M 0.98%
16,323
DOX icon
38
Amdocs
DOX
$5.92B
$4.07M 0.96%
58,026
-2,446
-4% -$185K
GNTX icon
39
Gentex
GNTX
$4.97B
$3.57M 0.84%
100,121
-4,347
-4% -$154K
TRU icon
40
TransUnion
TRU
$15.1B
$3.37M 0.79%
37,419
-14,982
-29% -$1.35M
SONY icon
41
Sony
SONY
$137B
$3.24M 0.76%
152,785
-22,150
-13% -$468K
BDX icon
42
Becton Dickinson
BDX
$45.6B
$2.91M 0.69%
12,267
-1,237
-9% -$302K
SWK icon
43
Stanley Black & Decker
SWK
$14.3B
$2.75M 0.65%
13,775
-392
-3% -$71.1K
WMT icon
44
Walmart Inc
WMT
$885B
$2.71M 0.64%
59,850
AXTA icon
45
Axalta
AXTA
$7.66B
$2.52M 0.59%
+85,240
New +$2.44M
VVV icon
46
Valvoline
VVV
$4.9B
$2.45M 0.58%
94,092
-19,455
-17% -$485K
DD icon
47
DuPont de Nemours
DD
$18.5B
$2.33M 0.55%
24,047
-3,191
-12% -$306K
RELX icon
48
RELX
RELX
$61.8B
$2.11M 0.5%
84,010
-7,508
-8% -$187K
SNY icon
49
Sanofi
SNY
$103B
$2.1M 0.5%
42,558
+2,614
+7% +$126K
MMM icon
50
3M
MMM
$90.9B
$2.07M 0.49%
12,821
-377
-3% -$56.4K

Similar funds

Foyston, Gordon, & Payne's Q1 2021 Portfolio in Review

As of Q1 2021, Foyston, Gordon, & Payne held 68 positions worth $424M, up 2.4% from $414M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Foyston, Gordon, & Payne's Q1 2021 filing shows 3 new, 11 increased, 40 reduced and 3 closed positions. Its largest new stake was Keysight: 43,402 shares worth $6.22M. The largest sale was Hershey, an estimated $5.44M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.

  • Foyston, Gordon, & Payne's largest Q1 2021 buy was Keysight: 43,402 shares worth $6.22M.
  • Foyston, Gordon, & Payne added most to Equifax in Q1 2021, an estimated $3.92M increase.
  • Foyston, Gordon, & Payne's biggest Q1 2021 reduction was Corteva, cutting an estimated $4.1M.
  • Foyston, Gordon, & Payne fully exited Hershey in Q1 2021, selling an estimated $5.44M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 45% of its $424M portfolio in Q1 2021.
  • Foyston, Gordon, & Payne opened 3 new positions and closed 3 in Q1 2021.
  • Foyston, Gordon, & Payne's portfolio value rose 2.4% quarter-over-quarter to $424M.

Based on Foyston, Gordon, & Payne's 13F filing for Q1 2021, filed 14 May 2021.